These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11451209)

  • 1. Clinical uses of tumor markers: a critical review.
    Duffy MJ
    Crit Rev Clin Lab Sci; 2001 Jun; 38(3):225-62. PubMed ID: 11451209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumor markers in patients with solid cancers: A critical review.
    Duffy MJ
    Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of circulating tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Biomarkers in Screening for Cancer.
    Duffy MJ
    Adv Exp Med Biol; 2015; 867():27-39. PubMed ID: 26530358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
    Sisinni L; Landriscina M
    Adv Exp Med Biol; 2015; 867():159-76. PubMed ID: 26530366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
    Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
    Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in breast cancer- European Group on Tumor Markers recommendations.
    Molina R; Barak V; van Dalen A; Duffy MJ; Einarsson R; Gion M; Goike H; Lamerz R; Nap M; Sölétormos G; Stieber P
    Tumour Biol; 2005; 26(6):281-93. PubMed ID: 16254457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers supplementing CA 125 in ovarian cancer.
    Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
    Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of tumour markers: a review.
    Amayo AA; Kuria JG
    East Afr Med J; 2009 Dec; 86(12 Suppl):S76-83. PubMed ID: 21591514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.
    Duffy MJ; Maguire TM; McDermott EW; O'Higgins N
    J Surg Oncol; 1999 Jun; 71(2):130-5. PubMed ID: 10389872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A personalized approach to cancer treatment: how biomarkers can help.
    Duffy MJ; Crown J
    Clin Chem; 2008 Nov; 54(11):1770-9. PubMed ID: 18801934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the clinical use of tumour markers.
    Duffy MJ
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):370-7. PubMed ID: 15333188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological markers of cancer. Critical study].
    Bellet D; Bidart JM
    Presse Med; 1993 Apr; 22(14):680-6. PubMed ID: 8511115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental proteins as tumor markers.
    Braunstein GD
    Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.